Trailhead Biosystems, a fast-growing biotechnology company with operations in Beachwood, has secured an additional $20 million in funding – bringing its total financing to $40 million – to accelerate commercialization, expand manufacturing capacity, and support continued growth.
The fi
nancing was led by MAK Capital, with participation from a group of existing and new investors. The expansion will also support high-skill scientific and operational jobs in Beachwood, drawing talent in cell biology, manufacturing, quality systems, and biotechnology operations.
Founded on cutting-edge research and innovation, Trailhead Biosystems develops human cells that help scientists better understand disease and advance drug discovery. The company specializes in transforming induced pluripotent stem cells (iPSCs) into functional human cell types that closely mirror how cells behave in the human body. These advanced models enable more accurate research results while reducing reliance on traditional animal testing.
Trailhead’s continued growth in Beachwood reflects both the strength of the region’s life sciences ecosystem and the City of Beachwood’s proactive approach to economic development. The city’s Economic Development Department worked closely with the company to support its decision to locate and grow in Beachwood, helping position the community as a destination for innovative biotechnology firms.
Accelerating Commercialization and Meeting Industry Demand
This latest funding round represents a significant milestone for Trailhead, providing resources to move more quickly from innovation to commercialization.
“This is a very meaningful raise for Trailhead,” said David Llewellyn, CEO. “It gives us the resources to expand our manufacturing capacity and continue building the quality systems and operational infrastructure required to support larger pharmaceutical and biotech customers. It is a strong validation of both our technology platform and our commercial momentum.”
Advancing Human-Relevant Research
The new funding will allow Trailhead to expand its portfolio of human cell products used in preclinical research, including drug discovery, toxicity testing, disease modeling, organoid research, and organ-on-a-chip applications. In addition to off-the-shelf products, the company also provides custom cell differentiation services for research partners seeking specialized human cell models.
A Strong Fit for Beachwood
Founded in 2015 as a spinoff from Cleveland Clinic and Case Western Reserve University, Trailhead builds on Northeast Ohio’s globally recognized strengths in biomedical research and innovation. From its Beachwood operations, the company supports pharmaceutical and biotechnology partners across the U.S. and globally.
“The decision to relocate the company’s operations to Beachwood was driven by a combination of factors aimed at fostering business growth and supporting employee well-being,” said Div Trivedi, COO. “The city also had a progressive approach toward the shared vision of building a biotech hub with Trailhead.”
Beachwood Named a Premier Biosciences Community
The City of Beachwood has been designated a Premier Biosciences Community by Ohio Life Sciences, the statewide organization representing more than 5,000 bioscience companies and institutions across Ohio. Modeled after nationally recognized best-practice programs, the designation recognizes communities that demonstrate strength in key areas essential to bioscience growth, including infrastructure, workforce access, real estate readiness, and a supportive business environment.
For companies like Trailhead Biosystems, the designation reflects Beachwood’s ongoing commitment to innovation and long-term growth in the life sciences sector. Through strategic planning and collaboration, the city’s Economic Development Department continues to position Beachwood as a competitive destination for bioscience and biotechnology companies in Northeast Ohio.
“The City of Beachwood is proud to be honored as an Ohio Life Sciences Premier Community,” said Mayor Justin Berns. “Through the city’s pro-business policies and intentional economic development strategies, we are supporting investments that attract and retain driving innovation in life sciences and medical technology.”
Credit: Published in the March 2026 edition of the Beachwood Buzz